The aim of the webinar is to showcase the findings from the most recent independent evaluation of the Prehab4Cancer programme, including new long-term survival data, and to highlight its impact on patient outcomes, financial benefits and wider system performance.
The event will provide an opportunity to share the growing evidence base for cancer prehabilitation, celebrate the achievements of the programme to date, and outline the future strategic direction of Prehab4Cancer.
Key objectives include:
- Presenting the latest evaluation findings and programme outcomes.
- Showcasing the evidence supporting the role of prehabilitation in improving patient outcomes, including long-term survival data.
- Sharing future plans for programme development through digital innovation and expansion to additional tumour groups.
- Engaging stakeholders to support the future growth, expansion, sustainability and collaborative delivery of Prehab4Cancer across Greater Manchester
This webinar is intended for Cancer pathway teams across Greater Manchester, including those currently referring into Prehab4Cancer (colorectal, lung and upper GI pathways) and tumour groups being considered for future expansion, such as head and neck, gynaecology, urology and hepatopancreatobiliary (HPB) cancers.
You can view the evaluation report the Prehab4Cancer Independent Evaluation Report at the bottom of this page.
You must be logged in to register for this event.